Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (SHE:300760)
168.40
+7.29 (4.52%)
Apr 29, 2026, 3:14 PM CST
SHE:300760 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Market Capitalization | 194,845 | 230,329 | 308,395 | 351,450 | 382,132 | 461,774 | Upgrade
|
| Market Cap Growth | -31.15% | -25.31% | -12.25% | -8.03% | -17.25% | -10.83% | Upgrade
|
| Enterprise Value | 181,835 | 218,119 | 295,955 | 332,043 | 366,958 | 449,158 | Upgrade
|
| Last Close Price | 161.11 | 190.45 | 249.78 | 276.81 | 292.26 | 348.13 | Upgrade
|
| PE Ratio | 24.91 | 28.31 | 26.43 | 30.34 | 39.78 | 57.71 | Upgrade
|
| Forward PE | 21.55 | 24.28 | 22.32 | 26.68 | 34.86 | 48.63 | Upgrade
|
| PS Ratio | 5.83 | 6.92 | 8.40 | 10.06 | 12.58 | 18.27 | Upgrade
|
| PB Ratio | 4.34 | 5.36 | 7.57 | 10.54 | 11.94 | 17.12 | Upgrade
|
| P/TBV Ratio | 8.56 | 11.35 | 17.10 | 13.62 | 14.93 | 22.34 | Upgrade
|
| P/FCF Ratio | 24.69 | 28.41 | 29.45 | 41.97 | 37.37 | 60.79 | Upgrade
|
| P/OCF Ratio | 19.42 | 22.70 | 24.81 | 31.77 | 31.47 | 51.32 | Upgrade
|
| PEG Ratio | 3.97 | 3.12 | 1.73 | 1.28 | 1.46 | 2.51 | Upgrade
|
| EV/Sales Ratio | 5.44 | 6.55 | 8.06 | 9.51 | 12.09 | 17.77 | Upgrade
|
| EV/EBITDA Ratio | 16.67 | 20.10 | 21.58 | 25.24 | 32.80 | 47.88 | Upgrade
|
| EV/EBIT Ratio | 19.86 | 23.46 | 23.92 | 27.08 | 35.25 | 51.25 | Upgrade
|
| EV/FCF Ratio | 23.05 | 26.90 | 28.26 | 39.66 | 35.89 | 59.13 | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | 0.03 | Upgrade
|
| Debt / FCF Ratio | 0.04 | 0.04 | 0.03 | 0.04 | 0.02 | 0.03 | Upgrade
|
| Net Debt / Equity Ratio | -0.41 | -0.41 | -0.40 | -0.56 | -0.72 | -0.56 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.62 | -1.62 | -1.19 | -1.40 | -2.05 | -1.61 | Upgrade
|
| Net Debt / FCF Ratio | -2.17 | -2.17 | -1.56 | -2.21 | -2.24 | -1.99 | Upgrade
|
| Asset Turnover | 0.57 | 0.57 | 0.70 | 0.74 | 0.72 | 0.71 | Upgrade
|
| Inventory Turnover | 2.77 | 2.77 | 3.15 | 3.19 | 2.89 | 2.50 | Upgrade
|
| Quick Ratio | 1.86 | 1.86 | 1.93 | 2.21 | 2.21 | 2.00 | Upgrade
|
| Current Ratio | 2.36 | 2.36 | 2.46 | 2.66 | 2.60 | 2.47 | Upgrade
|
| Return on Equity (ROE) | 20.18% | 20.18% | 31.69% | 35.44% | 32.60% | 31.85% | Upgrade
|
| Return on Assets (ROA) | 10.03% | 10.03% | 14.79% | 16.19% | 15.33% | 15.34% | Upgrade
|
| Return on Invested Capital (ROIC) | 30.94% | 32.60% | 56.83% | 91.30% | 87.42% | 79.76% | Upgrade
|
| Return on Capital Employed (ROCE) | 19.50% | 19.50% | 26.80% | 32.40% | 29.80% | 29.70% | Upgrade
|
| Earnings Yield | 4.02% | 3.53% | 3.78% | 3.30% | 2.51% | 1.73% | Upgrade
|
| FCF Yield | 4.05% | 3.52% | 3.40% | 2.38% | 2.68% | 1.65% | Upgrade
|
| Dividend Yield | 2.72% | 2.30% | 2.51% | 2.10% | 1.54% | 1.00% | Upgrade
|
| Payout Ratio | 71.64% | 69.01% | 74.92% | 92.12% | 44.06% | 37.98% | Upgrade
|
| Buyback Yield / Dilution | -0.03% | -0.03% | 0.04% | -0.11% | 0.36% | 0.07% | Upgrade
|
| Total Shareholder Return | 2.74% | 2.27% | 2.55% | 1.98% | 1.90% | 1.08% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.